SubsidieMeestersA natural breast for cancer survivors: resorbable implant supporting tissue regeneration
REGENERA aims to provide lumpectomy patients with a resorbable implant that promotes natural breast restoration through tissue self-regeneration, minimizing pain and follow-up surgeries.
Projectdetails
Introduction
Of the 3 million women undergoing breast cancer resection every year, only a few opt for breast reconstruction due to pain, concerns about follow-up procedures, and the lack of options.
Current Challenges
For lumpectomy patients, traditional implants cannot be used, with only ~20-30% of lumpectomies being reconstructed. Autologous tissue transfer requires multiple painful interventions to reconstruct large volumes and obtain satisfactory results.
Additional Concerns
Furthermore, both implants and autologous solutions require multiple follow-up surgeries, increasing costs and pain for the patients.
Proposed Solution
REGENERA will be a unique solution for lumpectomy patients: a resorbable implant designed to restore a natural breast through tissue self-regeneration.
Implant Features
- It is a cell-free porous scaffold made of resorbable biocompatible poly(urethane-ester-ether) with a biomimetic architecture.
- It is designed to avoid follow-up surgeries and eliminate the risks associated with silicone and saline implants (rupture, leakage, ALCL) and fat grafting.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.498.600 |
| Totale projectbegroting | € 3.569.441 |
Tijdlijn
| Startdatum | 1-3-2023 |
| Einddatum | 28-2-2025 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- TENSIVE SRLpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Breast self-reconstruction: The Promise of Breast Reconstruction with patients’ own tissueLATTICE MEDICAL's MATTISSE project aims to launch a fully degradable 3D printed breast implant for natural reconstruction, enhancing recovery and safety for women by 2030. | EIC Accelerator | € 2.438.488 | 2022 | Details |
The Holy Grail in Bone regenerationGreenBone aims to revolutionize bone grafts with a synthetic Rattan wood-based implant that mimics natural bone, enhancing regeneration and targeting the spinal market by 2025. | EIC Accelerator | € 2.458.128 | 2022 | Details |
BioProtect Balloon Implant System – Enabling Safe Prostate Radiation Treatment even at extreme dosageProSpace is a biodegradable balloon spacer that protects rectal tissue during prostate cancer radiation treatment by creating a safe distance between the prostate and rectum. | EIC Accelerator | € 2.500.000 | 2023 | Details |
Breast self-reconstruction: The Promise of Breast Reconstruction with patients’ own tissue
LATTICE MEDICAL's MATTISSE project aims to launch a fully degradable 3D printed breast implant for natural reconstruction, enhancing recovery and safety for women by 2030.
The Holy Grail in Bone regeneration
GreenBone aims to revolutionize bone grafts with a synthetic Rattan wood-based implant that mimics natural bone, enhancing regeneration and targeting the spinal market by 2025.
BioProtect Balloon Implant System – Enabling Safe Prostate Radiation Treatment even at extreme dosage
ProSpace is a biodegradable balloon spacer that protects rectal tissue during prostate cancer radiation treatment by creating a safe distance between the prostate and rectum.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Dan Jing WuVivArt-X ontwikkelt een innovatief synthetisch biomateriaal voor veiligere en effectievere borstreconstructie na borstamputatie. | Mkb-innovati... | € 19.320 | 2023 | Details |
ArvinaArvina ontwikkelt een synthetisch biomateriaal voor effectieve borstreconstructie, ter verbetering van de levenskwaliteit van borstkankerpatiënten. | 1.1 - Het ve... | € 482.195 | 2023 | Details |
BioBone: Bioactive Hydrogel-based Implants to Induce Bone RegenerationThe project aims to enhance bone regeneration after tumor resection by developing 3D-printed porous titanium implants integrated with bioactive materials, improving patient outcomes and reducing complications. | ERC Proof of... | € 150.000 | 2024 | Details |
Transforming bone cancer therapy with composite biomaterials encapsulating plasma-generated RONSTRANSFORMER aims to develop a novel therapy combining cold atmospheric plasma-treated hydrogels with biomaterials for simultaneous osteosarcoma treatment and bone regeneration, enhancing patient outcomes. | ERC Proof of... | € 150.000 | 2022 | Details |
Engineering and Delivering B Cells Using Biomaterials against Breast CancerEND-BC aims to enhance B cell adoptive cell therapy for breast cancer using novel biomaterials to improve efficacy, reduce side effects, and lower treatment costs. | ERC Proof of... | € 150.000 | 2024 | Details |
Dan Jing Wu
VivArt-X ontwikkelt een innovatief synthetisch biomateriaal voor veiligere en effectievere borstreconstructie na borstamputatie.
Arvina
Arvina ontwikkelt een synthetisch biomateriaal voor effectieve borstreconstructie, ter verbetering van de levenskwaliteit van borstkankerpatiënten.
BioBone: Bioactive Hydrogel-based Implants to Induce Bone Regeneration
The project aims to enhance bone regeneration after tumor resection by developing 3D-printed porous titanium implants integrated with bioactive materials, improving patient outcomes and reducing complications.
Transforming bone cancer therapy with composite biomaterials encapsulating plasma-generated RONS
TRANSFORMER aims to develop a novel therapy combining cold atmospheric plasma-treated hydrogels with biomaterials for simultaneous osteosarcoma treatment and bone regeneration, enhancing patient outcomes.
Engineering and Delivering B Cells Using Biomaterials against Breast Cancer
END-BC aims to enhance B cell adoptive cell therapy for breast cancer using novel biomaterials to improve efficacy, reduce side effects, and lower treatment costs.